Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The blood cell plasma membrane is a dynamic lipid bilayer embedded with proteins such as transporters (e.g., band 3 anion exchanger), structural components (spectrin, actin, ankyrin, protein 4.1R), and glycoproteins/glycolipids that mediate recognition and adhesion[1][4][5]. This structure provides the cell with selective permeability, mechanical durability, deformability, and the ability to participate in cell signaling and communication. Defects or mismatches in membrane composition can lead to disease or immune dysfunction. It should be noted that “blood cell membrane” is not a molecular therapeutic target but a composite biological barrier containing many actual molecular targets within its structure[1][5][6].
For drugs: changes to membrane fluidity, permeability, or protein function by interacting with discrete membrane proteins or lipids. Some drugs bind to red cell membrane antigens, leading to immunologic removal
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood cell plasma membrane.